These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 17978999)

  • 1. Genetic variation in mu-opioid-receptor-interacting proteins and smoking cessation in a nicotine replacement therapy trial.
    Ray R; Jepson C; Wileyto EP; Dahl JP; Patterson F; Rukstalis M; Pinto A; Berrettini W; Lerman C
    Nicotine Tob Res; 2007 Nov; 9(11):1237-41. PubMed ID: 17978999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the mu-opioid receptor gene with smoking cessation.
    Munafò MR; Elliot KM; Murphy MF; Walton RT; Johnstone EC
    Pharmacogenomics J; 2007 Oct; 7(5):353-61. PubMed ID: 17224915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trial.
    Lerman C; Wileyto EP; Patterson F; Rukstalis M; Audrain-McGovern J; Restine S; Shields PG; Kaufmann V; Redden D; Benowitz N; Berrettini WH
    Pharmacogenomics J; 2004; 4(3):184-92. PubMed ID: 15007373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Shiffman S
    Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials.
    Lerman C; Jepson C; Wileyto EP; Epstein LH; Rukstalis M; Patterson F; Kaufmann V; Restine S; Hawk L; Niaura R; Berrettini W
    Neuropsychopharmacology; 2006 Jan; 31(1):231-42. PubMed ID: 16123753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CHRNA4 and tobacco dependence: from gene regulation to treatment outcome.
    Hutchison KE; Allen DL; Filbey FM; Jepson C; Lerman C; Benowitz NL; Stitzel J; Bryan A; McGeary J; Haughey HM
    Arch Gen Psychiatry; 2007 Sep; 64(9):1078-86. PubMed ID: 17768273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of gene-drug interactions in smoking cessation for improving the prevention of chronic degenerative diseases.
    Quaak M; van Schayck CP; Knaapen AM; van Schooten FJ
    Mutat Res; 2009 Jul; 667(1-2):44-57. PubMed ID: 19028511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized trial of nicotine replacement therapy in combination with reduced-nicotine cigarettes for smoking cessation.
    Becker KM; Rose JE; Albino AP
    Nicotine Tob Res; 2008 Jul; 10(7):1139-48. PubMed ID: 18629723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of association of 5-HTTLPR genotype with smoking cessation in a nicotine replacement therapy randomized trial.
    Munafò MR; Johnstone EC; Wileyto EP; Shields PG; Elliot KM; Lerman C
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):398-400. PubMed ID: 16492936
    [No Abstract]   [Full Text] [Related]  

  • 10. Smoking cessation patterns in methadone-maintained smokers.
    Stein MD; Anderson BJ; Niaura R
    Nicotine Tob Res; 2007 Mar; 9(3):421-8. PubMed ID: 17365774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study.
    Gelernter J; Gueorguieva R; Kranzler HR; Zhang H; Cramer J; Rosenheck R; Krystal JH;
    Alcohol Clin Exp Res; 2007 Apr; 31(4):555-63. PubMed ID: 17374034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Family support and employment as predictors of smoking cessation success: a randomized, double-blind, placebo-controlled trial of nicotine sublingual tablets in chinese smokers.
    Sun HQ; Guo S; Chen DF; Jiang ZN; Liu Y; Di XL; Yang FD; Zhang XY; Kosten TR; Lu L
    Am J Drug Alcohol Abuse; 2009; 35(3):183-8. PubMed ID: 19462302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quitting by gradual smoking reduction using nicotine gum: a randomized controlled trial.
    Shiffman S; Ferguson SG; Strahs KR
    Am J Prev Med; 2009 Feb; 36(2):96-104.e1. PubMed ID: 19135903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of the DRD2 polymorphism on smoking cessation and negative affect: evidence for a pharmacogenetic effect on mood.
    Cinciripini P; Wetter D; Tomlinson G; Tsoh J; De Moor C; Cinciripini L; Minna J
    Nicotine Tob Res; 2004 Apr; 6(2):229-39. PubMed ID: 15203796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction between variation in the D2 dopamine receptor (DRD2) and the neuronal calcium sensor-1 (FREQ) genes in predicting response to nicotine replacement therapy for tobacco dependence.
    Dahl JP; Jepson C; Levenson R; Wileyto EP; Patterson F; Berrettini WH; Lerman C
    Pharmacogenomics J; 2006; 6(3):194-9. PubMed ID: 16402081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electronic monitoring of long-term use of the nicotine nasal spray and predictors of success in a smoking cessation program.
    Schneider MP; van Melle G; Uldry C; Huynh-Ba M; Fallab Stubi CL; Iorillo D; Burnier M; Zellweger JP
    Nicotine Tob Res; 2003 Oct; 5(5):719-27. PubMed ID: 14577988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of association of DRD2 rs1800497 (Taq1A) polymorphism with smoking cessation in a nicotine replacement therapy randomized trial.
    Munafò MR; Johnstone EC; Murphy MF; Aveyard P
    Nicotine Tob Res; 2009 Apr; 11(4):404-7. PubMed ID: 19273465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotine dependence, psychological distress and personality traits as possible predictors of smoking cessation. Results of a double-blind study with nicotine patch.
    Cosci F; Corlando A; Fornai E; Pistelli F; Paoletti P; Carrozzi L
    Addict Behav; 2009 Jan; 34(1):28-35. PubMed ID: 18804918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does extended proactive telephone support increase smoking cessation among low-income women using nicotine patches?
    Solomon LJ; Marcy TW; Howe KD; Skelly JM; Reinier K; Flynn BS
    Prev Med; 2005 Mar; 40(3):306-13. PubMed ID: 15533544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose nicotine patch therapy for smokers with a history of alcohol dependence: 36-week outcomes.
    Kalman D; Kahler CW; Garvey AJ; Monti PM
    J Subst Abuse Treat; 2006 Apr; 30(3):213-7. PubMed ID: 16616165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.